Herpes simplex infection - Symptoms, Causes, Treatment & Prevention

📅 Updated: April 2026 ⏱ 7 min read ✅ Medically reviewed
```html Herpes Simplex Infection – Comprehensive Medical Guide

Overview

Herpes simplex infection is a viral disease caused by two closely related viruses: herpes simplex virus‑1 (HSV‑1) and herpes simplex virus‑2 (HSV‑2). While HSV‑1 most often causes oral lesions (cold sores), it can also cause genital herpes. HSV‑2 is the predominant cause of genital infections, but both viruses can infect either site through oral‑genital contact.

The infection is lifelong. After the initial outbreak, the virus retreats to nerve ganglia and can reactivate periodically, leading to recurrent sores. About one in six people (≈16%) in the United States ages 14‑49 are infected with HSV‑2, and roughly 50% of adults carry HSV‑1, most of whom were infected in childhood.

Anyone who is sexually active, shares personal items that touch the mouth (e.g., lip balm, utensils), or has a weakened immune system can acquire the virus. The disease is not limited by age, gender, race, or socioeconomic status.

Symptoms

Many people with HSV are asymptomatic or have only mild symptoms that go unnoticed. When symptoms appear, they usually develop within 2‑12 days after exposure.

  • Primary (first) outbreak – May include:
    • Fever, chills, headache, or muscle aches.
    • Swollen, tender lymph nodes (usually in the neck or groin).
    • Multiple painful vesicles (small fluid‑filled blisters) on the lips, gums, tongue, inside the mouth, or on the genitals/anus.
    • Ulcers that rupture and form shallow sores that crust over within 7‑10 days.
  • Recurrent (subsequent) outbreaks – Typically milder and shorter:
    • Prodrome sensation (tingling, itching, or burning) 12‑48 hours before lesions appear.
    • One to several grouped vesicles that become painful ulcers.
    • Healing usually occurs within 3‑5 days without scarring.
  • Genital herpes specific signs:
    • Redness, swelling, and tender bumps on the penis, vulva, cervix, anus, or thighs.
    • Pain during urination if lesions are near the urethra.
    • Flu‑like symptoms (especially during the first episode).
  • Ocular herpes (HSV‑1) – Can cause:
    • Red, watery eye with pain.
    • Blurred vision, photophobia.
    • Corneal ulceration (potentially sight‑threatening).
  • Neonatal herpes – In newborns infected during delivery:
    • Skin, eyes, and mouth lesions.
    • Fever, lethargy, seizures.
    • Disseminated disease affecting liver, lungs, or brain.

Causes and Risk Factors

HSV is spread through direct contact with infected skin or mucous membranes. The virus cannot survive long outside the body, but it is highly contagious while lesions are present, and also during asymptomatic viral shedding.

Transmission pathways

  • Oral‑to‑oral: Kissing, sharing toothbrushes, eating utensils, or lip‑balm.
  • Oral‑to‑genital: Oral sex can transfer HSV‑1 to the genital area.
  • Genital‑to‑genital: Vaginal, anal, or oral sex with an infected partner.
  • Mother‑to‑child: Birth (especially if the mother has active genital lesions); rarely via breast‑milk.

Risk factors

  • Having multiple sexual partners or a partner with HSV.
  • Unprotected sexual activity (condom use reduces but does not eliminate risk).
  • Existing sexually transmitted infections (STIs) that compromise mucosal integrity.
  • Weakened immunity – HIV infection, organ transplant, chemotherapy, or chronic steroid use.
  • Teenage years – higher rates of new HSV‑2 infection due to behavioral factors.
  • Pregnancy – hormonal changes can increase frequency of outbreaks.

Diagnosis

Clinical presentation is often sufficient for a presumptive diagnosis, but laboratory confirmation is recommended, especially for first‑time genital lesions, pregnant women, or immunocompromised patients.

Laboratory tests

  • Polymerase Chain Reaction (PCR): Detects HSV DNA from lesion swabs, blood, cerebrospinal fluid, or amniotic fluid. It is the most sensitive test (>95% sensitivity).
  • Viral culture: Less commonly used now; good specificity but lower sensitivity (≈70%).
  • Direct fluorescent antibody (DFA): Quick bedside test; useful in clinics with appropriate equipment.
  • Serologic testing: Blood tests for HSV‑1 and HSV‑2 IgG antibodies. Helpful when lesions are absent; cannot distinguish recent from remote infection.
  • Type‑specific IgG ELISA: Differentiates HSV‑1 from HSV‑2 antibodies with >98% accuracy (recommended by CDC for seroprevalence studies).

Additional evaluations

  • Complete blood count (CBC) if systemic symptoms are present.
  • Liver function tests for patients on antiviral therapy (rarely needed).
  • Ophthalmologic exam for suspected ocular herpes.
  • Neonatal evaluation (PCR of skin, eye, mouth swabs) if congenital infection is suspected.

Treatment Options

There is no cure; therapy aims to shorten outbreak duration, reduce pain, limit viral shedding, and prevent complications.

Antiviral medications

MedicationTypical DoseIndications
Acyclovir 200‑400 mg 5×/day (oral); 5‑10 mg/kg IV q8h Primary/genital outbreaks, neonatal, CNS involvement
Valacyclovir 1 g twice daily (oral) for 7‑10 days; 500 mg daily suppressive Genital herpes, recurrent oral lesions, suppressive therapy
Famciclovir 250 mg three times daily (oral) for 7‑10 days Genital and oral recurrences; alternative to valacyclovir

For immunocompromised patients or severe disease (e.g., encephalitis, disseminated neonatal infection), intravenous acyclovir is standard.

Suppressive therapy

  • Daily oral valacyclovir 500 mg or acyclovir 400 mg twice daily reduces genital shedding by ~70% and lowers transmission risk to partners (CDC, 2022).
  • Suppression is recommended for:
    • ≄4 outbreaks/year.
    • Pregnant women with genital HSV‑2 (to reduce birth‑channel transmission).
    • Immunocompromised individuals.

Procedural interventions

  • Topical anesthetics (lidocaine, benzocaine) to relieve pain.
  • Cauterization or laser therapy for frequent, painful genital lesions unresponsive to antivirals (rare).
  • Management of ocular disease: Prompt antiviral eye drops (trifluridine) or oral therapy plus ophthalmology follow‑up.

Lifestyle & supportive care

  • Keep lesions clean and dry; avoid touching them.
  • Use over‑the‑counter analgesics (acetaminophen, ibuprofen) for discomfort.
  • Cool compresses can reduce swelling.
  • Maintain good nutrition and adequate sleep to support immune function.

Living with Herpes Simplex Infection

Although a diagnosis can be emotionally distressing, most people lead normal, healthy lives.

Practical daily‑management tips

  1. Track outbreaks – Use a diary or app to note prodrome timing, triggers, and lesion duration. This helps your clinician tailor therapy.
  2. Practice safe sex – Use condoms or dental dams even when lesions are absent; discuss suppressive therapy with partners.
  3. Avoid triggering factors – Sunlight, stress, illness, and hormonal fluctuations (menstruation) can precipitate recurrences; sunscreen on lips and stress‑reduction techniques (yoga, meditation) are useful.
  4. Personal hygiene – Wash hands thoroughly after touching lesions; do not share towels, razors, or lip balms.
  5. Pregnancy considerations – Inform obstetrician early; suppressive therapy from week 36 onward reduces neonatal transmission to <1% (vs. ~30% without treatment).
  6. Emotional support – Join support groups, seek counseling if anxiety or depression arises; reputable resources include the American Sexual Health Association.

Prevention

  • Abstinence or mutually monogamous relationships with an uninfected partner are most effective.
  • Consistent condom or dental‑dam use lowers genital HSV transmission by ~50% (CDC, 2023).
  • Avoid sexual activity during active lesions or prodrome.
  • Do not share personal items that contact oral secretions.
  • For HSV‑2–positive pregnant women, consider antiviral suppressive therapy starting at 36 weeks gestation to prevent neonatal infection.
  • Vaccines are under investigation; no licensed vaccine exists as of 2024.

Complications

Complications are uncommon in immunocompetent adults but can be serious if left untreated.

  • Neonatal herpes – Mortality up to 30% without treatment; survivors may have neurodevelopmental deficits.
  • Herpes encephalitis – HSV‑1 is the leading cause of sporadic fatal encephalitis; mortality >70% without prompt IV acyclovir.
  • Ocular disease – Recurrent keratitis can lead to corneal scarring and vision loss.
  • Genital scarring – Repeated ulcerations may cause urethral strictures in men or dyspareunia in women.
  • Increased HIV acquisition risk – Genital ulceration multiplies HIV transmission risk by up to 3‑fold.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you notice any of the following:
  • Severe headache, fever, neck stiffness, or altered mental status – possible herpes encephalitis.
  • Sudden painful eye redness with vision loss – possible ocular herpes keratitis.
  • High fever, rapid breathing, and a rash that includes the palms or soles – may indicate disseminated HSV infection.
  • Signs of bacterial superinfection of lesions (increasing redness, pus, swelling, foul odor).
  • Newborn with blisters, fever, or lethargy – suspect neonatal herpes.
Prompt treatment can dramatically improve outcomes.

References

```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References